CLRB
Price
$5.09
Change
-$0.26 (-4.86%)
Updated
Jul 25 closing price
Capitalization
14.54M
22 days until earnings call
QTTB
Price
$2.21
Change
-$0.10 (-4.33%)
Updated
Jul 25 closing price
Capitalization
26.96M
Interact to see
Advertisement

CLRB vs QTTB

Header iconCLRB vs QTTB Comparison
Open Charts CLRB vs QTTBBanner chart's image
Cellectar Biosciences
Price$5.09
Change-$0.26 (-4.86%)
Volume$97.69K
Capitalization14.54M
Q32 Bio
Price$2.21
Change-$0.10 (-4.33%)
Volume$214.1K
Capitalization26.96M
CLRB vs QTTB Comparison Chart in %
Loading...
CLRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QTTB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLRB vs. QTTB commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLRB is a Hold and QTTB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 28, 2025
Stock price -- (CLRB: $5.09 vs. QTTB: $2.21)
Brand notoriety: CLRB and QTTB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLRB: 15% vs. QTTB: 12%
Market capitalization -- CLRB: $14.54M vs. QTTB: $26.96M
CLRB [@Biotechnology] is valued at $14.54M. QTTB’s [@Biotechnology] market capitalization is $26.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLRB’s FA Score shows that 0 FA rating(s) are green whileQTTB’s FA Score has 0 green FA rating(s).

  • CLRB’s FA Score: 0 green, 5 red.
  • QTTB’s FA Score: 0 green, 5 red.
According to our system of comparison, QTTB is a better buy in the long-term than CLRB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLRB’s TA Score shows that 4 TA indicator(s) are bullish while QTTB’s TA Score has 5 bullish TA indicator(s).

  • CLRB’s TA Score: 4 bullish, 6 bearish.
  • QTTB’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, QTTB is a better buy in the short-term than CLRB.

Price Growth

CLRB (@Biotechnology) experienced а +2.00% price change this week, while QTTB (@Biotechnology) price change was +0.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

CLRB is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QTTB($27M) has a higher market cap than CLRB($14.5M). QTTB YTD gains are higher at: -35.756 vs. CLRB (-43.255). CLRB has less debt than QTTB: CLRB (474K) vs QTTB (18.8M).
CLRBQTTBCLRB / QTTB
Capitalization14.5M27M54%
EBITDAN/A-40.39M-
Gain YTD-43.255-35.756121%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A65.5M-
Total Debt474K18.8M3%
FUNDAMENTALS RATINGS
CLRB vs QTTB: Fundamental Ratings
CLRB
QTTB
OUTLOOK RATING
1..100
497
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
43
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9653
P/E GROWTH RATING
1..100
77100
SEASONALITY SCORE
1..100
5024

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QTTB's Valuation (43) in the null industry is in the same range as CLRB (56) in the Biotechnology industry. This means that QTTB’s stock grew similarly to CLRB’s over the last 12 months.

QTTB's Profit vs Risk Rating (100) in the null industry is in the same range as CLRB (100) in the Biotechnology industry. This means that QTTB’s stock grew similarly to CLRB’s over the last 12 months.

QTTB's SMR Rating (100) in the null industry is in the same range as CLRB (100) in the Biotechnology industry. This means that QTTB’s stock grew similarly to CLRB’s over the last 12 months.

QTTB's Price Growth Rating (53) in the null industry is somewhat better than the same rating for CLRB (96) in the Biotechnology industry. This means that QTTB’s stock grew somewhat faster than CLRB’s over the last 12 months.

CLRB's P/E Growth Rating (77) in the Biotechnology industry is in the same range as QTTB (100) in the null industry. This means that CLRB’s stock grew similarly to QTTB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLRBQTTB
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 18 days ago
83%
Bullish Trend 5 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
82%
Aroon
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CLRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QTTB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LOMA11.620.17
+1.48%
Loma Negra Compania Industrial Argentina Sociedad Anonima
NECB22.500.20
+0.90%
NorthEast Community Bancorp
AVT53.500.16
+0.30%
Avnet
TEAM199.83N/A
N/A
Atlassian Corp
SOS7.03-0.04
-0.57%
SOS Limited

CLRB and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLRB has been loosely correlated with QTTB. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if CLRB jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLRB
1D Price
Change %
CLRB100%
-4.86%
QTTB - CLRB
64%
Loosely correlated
-4.33%
IBRX - CLRB
41%
Loosely correlated
-4.98%
ADCT - CLRB
40%
Loosely correlated
+1.55%
ANAB - CLRB
36%
Loosely correlated
-0.19%
PRAX - CLRB
35%
Loosely correlated
+2.09%
More

QTTB and

Correlation & Price change

A.I.dvisor indicates that over the last year, QTTB has been loosely correlated with CLRB. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if QTTB jumps, then CLRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QTTB
1D Price
Change %
QTTB100%
-4.33%
CLRB - QTTB
64%
Loosely correlated
-4.86%
MESO - QTTB
51%
Loosely correlated
-3.65%
STOK - QTTB
49%
Loosely correlated
-3.03%
ADCT - QTTB
46%
Loosely correlated
+1.55%
ANAB - QTTB
39%
Loosely correlated
-0.19%
More